- Home
- KYMR vs KLIC Comparison
KYMR vs KLIC Comparison
Compare KYMR & KLIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- KLIC
- Stock Information
- Founded
- KYMR 2015
- KLIC 1951
- Country
- KYMR United States
- KLIC United States
- Employees
- KYMR N/A
- KLIC N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- KLIC Semiconductors
- Sector
- KYMR Health Care
- KLIC Technology
- Exchange
- KYMR Nasdaq
- KLIC Nasdaq
- Market Cap
- KYMR 1.8B
- KLIC 1.7B
- IPO Year
- KYMR 2020
- KLIC N/A
- Fundamental
- Price
- KYMR $29.64
- KLIC $32.15
- Analyst Decision
- KYMR Buy
- KLIC Strong Buy
- Analyst Count
- KYMR 15
- KLIC 4
- Target Price
- KYMR $55.47
- KLIC $48.00
- AVG Volume (30 Days)
- KYMR 650.3K
- KLIC 661.4K
- Earning Date
- KYMR 05-09-2025
- KLIC 05-06-2025
- Dividend Yield
- KYMR N/A
- KLIC 2.55%
- EPS Growth
- KYMR N/A
- KLIC N/A
- EPS
- KYMR N/A
- KLIC 0.40
- Revenue
- KYMR $58,885,000.00
- KLIC $691,079,000.00
- Revenue This Year
- KYMR $32.80
- KLIC N/A
- Revenue Next Year
- KYMR $8.88
- KLIC $14.33
- P/E Ratio
- KYMR N/A
- KLIC $81.01
- Revenue Growth
- KYMR N/A
- KLIC N/A
- 52 Week Low
- KYMR $19.45
- KLIC $26.63
- 52 Week High
- KYMR $53.27
- KLIC $53.71
- Technical
- Relative Strength Index (RSI)
- KYMR 48.27
- KLIC 46.79
- Support Level
- KYMR $28.06
- KLIC $32.22
- Resistance Level
- KYMR $30.28
- KLIC $33.16
- Average True Range (ATR)
- KYMR 1.65
- KLIC 0.78
- MACD
- KYMR -0.19
- KLIC -0.08
- Stochastic Oscillator
- KYMR 27.96
- KLIC 24.23
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About KLIC Kulicke and Soffa Industries Inc.
Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.